Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Prurigo Nodularis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Other
Participants:
20
Start Date:
February 2021
Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
400
Start Date:
December 15, 2020
A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
270
Start Date:
September 11, 2020
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
270
Start Date:
August 11, 2020
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
150
Start Date:
January 16, 2020
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug
Participants:
150
Start Date:
December 12, 2019
A Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Prurigo Nodularis Who Are Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
230
Start Date:
March 11, 2019
A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL-716 in Reducing Pruritus in Subjects With Prurigo Nodularis
Clinical Trial
Status:
Recruiting
Phase:
Phase 2/Phase 3
Intervention Type:
Drug, Other
Participants:
360
Start Date:
August 7, 2018
A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm , Efficacy and Safety Study in Prurigo Nodularis (PN) With Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRISM Study)
Showing 1-8 of 8